← All diseases Cancer

Anaplastic thyroid carcinoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (20)Meta-analysis (9)Treatment guideline (3)Systematic review (6)Phase 3 study (2)Clinical trial (90)Review article (144)Early study (phase 1 or 2) (46)Case report (144)Laboratory or animal study (46)Commentary or editorial (16)Retracted publication (3) Studies currently recruiting participants only (32)

Filter

Publications and studies (1124)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review. (2026/06/22) ♡
• Surgical Management and Outcomes in Advanced Thyroid Cancer: Insights from a Single-Institution Experience. (2026/06/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities. (2026/06/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Thyroid cancer and double-strand DNA break repair: The potential role of the MRN complex pathogenic variants. (2026/06/17) ♡
• Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer. (2026/06/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Anaplastic Thyroid Carcinoma Presenting with Gastrointestinal Bleeding: A Case Report and Literature Review. (2026/06/14) ♡
• The NAT10/c-Myc positive feedback loop orchestrates tRNA ac(4)C modification and OTUB1-mediated protein stabilization to drive anaplastic thyroid carcinoma progression. (2026/06/12) ♡
• Frequency of Thyroid Cancer in Multinodular Goiter Undergoing Thyroidectomy in Tertiary Care Centre in Pakistan: A Cross-Sectional Analysis. (2026/06/10) ♡
• Identification of ANC-3 as a Novel Therapeutic Candidate for Anaplastic Thyroid Cancer Through Drug Screening and Multi-Platform Validation. (2026/06/09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort. (2026/06/06) ♡
• Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer. (2026/06/06) ♡
• MAPK pathway inhibitors enhance radioiodine sensitivity in anaplastic thyroid carcinoma through promoting NIS expression and ARF4-mediated NIS membrane transport. (2026/06/04) ♡
• Dendrobine inhibits anaplastic thyroid cancer progression by targeting the JAK-STAT3 pathway. (2026/06/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chemokines in thyroid cancer: Mechanistic insights and clinical implications. (2026/06/01) ♡
• S1PR1-Overexpressing Membrane-Coated Nanoparticles Inhibit Dedifferentiation Progression for the Treatment of Anaplastic Thyroid Carcinoma by Targeting the ACER3/SPHK1/S1P Pathway. (2026/06/01) ♡
• TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma. (2026/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population. (2026/06/01) ♡
• Myeloid-derived suppressor cells in anaplastic thyroid carcinoma: insights from prospective immune profiling and implications for targeted immunotherapy. (2026/05/26) ♡
• Indications and Complications of Total Thyroidectomy in the Management of Thyroid Diseases: A Five-Year Retrospective Study in a Greek Population. (2026/05/26) ♡
• [Mechanism of timosaponin AⅢ liposomes loaded with auranofin in inducing ferroptosis in anaplastic thyroid carcinoma]. (2026/05/23) ♡
• Trends in metastatic thyroid cancer survival from 1992 to 2022: a SEER database analysis. (2026/05/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Precision Thyroid Oncology: A Review of Multi-Omics Biomarkers and Spatiotemporal Technologies. (2026/05/18) ♡
• A RAIR-ATC transcriptional axis and multimodal drug-response modelling reveal class-level vulnerabilities in thyroid cancer. (2026/05/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Anaplastic Thyroid Carcinoma With Cardiac Dysfunction Developed During Combination Therapy With Dabrafenib and Trametinib. (2026/05/18) ♡
• Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients. (2026/05/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Thyroid Cancer in the Elderly. (2026/05/11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers. (2026/05/07) ♡
• Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany. (2026/05/04) ♡
• Inhibitory effect of vemurafenib combined with panobinostat on human anaplastic thyroid cancer cells. (2026/05/01) ♡
• Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas. (2026/05/01) ♡
• Clinicopathological profile of high-grade differentiated thyroid carcinoma in an Indonesian tertiary hospital. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular findings in thyroid tumors: Practical diagnostic, prognostic, and therapeutic insights. (2026/05/01) ♡
• ALDH+ Anaplastic Thyroid Cancer Cells Show Vulnerability to a Pharmacologic Inducer of Centrosome Declustering. (2026/05/01) ♡
• Direct coupling and protective activation of DRP1 by the DNA-PKcs inhibitor KU-57788 synergizes with ferroptosis in anaplastic thyroid cancer cells. (2026/04/28) ♡
• Correction: RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex. (2026/04/28) ♡
• Anaplastic Thyroid Carcinoma With Predominant Intrathoracic Progression: A Case Report. (2026/04/27) ♡
• Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib. (2026/04/25) ♡
• Preliminary study on ketone body metabolism in anaplastic thyroid cancer. (2026/04/24) ♡
• Roundup(®) Original DI promotes proliferation in papillary thyroid carcinoma cells: a comparative study highlighting cell-type-dependent effects. (2026/04/23) ♡
• PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling. (2026/04/23) ♡
• Identification and molecular typing of disulfidptosis-related biomarkers in anaplastic thyroid carcinoma. (2026/04/22) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial. (2026/04/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Concurrent Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma Presenting With Hoarseness and Dysphagia. (2026/04/02) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The efficacy of various treatment modalities and their combinations in improving survival outcomes for anaplastic thyroid cancer: a systematic review and network meta-analysis. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy in Thyroid Cancer: Current Strategies and Challenges. (2026/04/01) ♡
• A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study. (2026/03/31) ♡
• Study on the inhibition of thyroid undifferentiated carcinoma metastasis by nanoparticles loaded with EZH2 inhibitor. (2026/03/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. From Cytology to Frozen Section: Diagnostic Challenges in Riedel's Thyroiditis-A Case Report and Brief Literature Review. (2026/03/26) ♡
• Isobavachalcone induces concurrent apoptosis and pyroptosis in anaplastic thyroid cancer cells by modulating the caspase-mediated cleavage of PARP and GSDME. (2026/03/15) ♡
• A case of poorly differentiated thyroid carcinoma harboring an SMARCB1 mutation. (2026/03/10) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.